Eintrag weiter verarbeiten
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
Gespeichert in:
Veröffentlicht in: | British journal of cancer 106(2012), 6, Seite 1239-1245 |
---|---|
Personen und Körperschaften: | , , |
Titel: | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial/ A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor |
Format: | E-Book-Kapitel |
Sprache: | Englisch |
veröffentlicht: |
21 February 2012
|
Gesamtaufnahme: |
: British journal of cancer, 106(2012), 6, Seite 1239-1245
, volume:106 |
Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
LEADER | 03851caa a2200577 4500 | ||
---|---|---|---|
001 | 0-1575856409 | ||
003 | DE-627 | ||
005 | 20220814151832.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180530s2012 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/bjc.2012.53 |2 doi | |
035 | |a (DE-627)1575856409 | ||
035 | |a (DE-576)505856409 | ||
035 | |a (DE-599)BSZ505856409 | ||
035 | |a (OCoLC)1341010401 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Schulz, Anna |d 1984- |e VerfasserIn |0 (DE-588)1057967998 |0 (DE-627)796229406 |0 (DE-576)413967948 |4 aut | |
245 | 1 | 0 | |a Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer |b results of the FOGT-4 trial |c A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor |
264 | 1 | |c 21 February 2012 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 30.05.2018 | ||
520 | |a Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials. | ||
700 | 1 | |a Knebel Doeberitz, Magnus von |e VerfasserIn |0 (DE-588)1022165291 |0 (DE-627)71693289X |0 (DE-576)364934239 |4 aut | |
700 | 1 | |a Kloor, Matthias |d 1972- |e VerfasserIn |0 (DE-588)124552803 |0 (DE-627)363416609 |0 (DE-576)294228616 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d Edinburgh : Nature Publ. Group, 1999 |g 106(2012), 6, Seite 1239-1245 |h Online-Ressource |w (DE-627)320420094 |w (DE-600)2002452-6 |w (DE-576)103746854 |x 1532-1827 |7 nnns |
773 | 1 | 8 | |g volume:106 |g year:2012 |g number:6 |g pages:1239-1245 |g extent:7 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/bjc.2012.53 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://www.nature.com/articles/bjc201253 |x Verlag |z kostenfrei |3 Volltext |
936 | u | w | |d 106 |j 2012 |e 6 |h 1239-1245 |g 7 |
951 | |a AR | ||
856 | 4 | 0 | |u https://www.nature.com/articles/bjc201253 |9 LFER |
852 | |a LFER |z 2019-05-07T00:00:00Z | ||
970 | |c OD | ||
971 | |c EBOOK | ||
972 | |c EBOOK | ||
973 | |c Aufsatz | ||
935 | |a lfer | ||
900 | |a Tikidzhieva, Anna | ||
900 | |a Kloor, Matthias Johannes | ||
900 | |a Knebel Döberitz, Magnus von | ||
900 | |a Knebel-Doeberitz, Magnus von | ||
900 | |a Doeberitz, Magnus Knebel von | ||
900 | |a Doeberitz, Magnus K. von | ||
900 | |a Knebel Doeberitz, M. von | ||
951 | |b XA-DE | ||
951 | |b XA-RU | ||
980 | |a 1575856409 |b 0 |k 1575856409 |o 505856409 |c lfer |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Microsatellite+instability+and+Beta2-Microglobulin+mutations+as+prognostic+markers+in+colon+cancer%3A+results+of+the+FOGT-4+trial&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Schulz%2C+Anna&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1532-1827 |
---|
_version_ | 1757949574849232896 |
---|---|
access_facet | Electronic Resources |
author | Schulz, Anna, Knebel Doeberitz, Magnus von, Kloor, Matthias |
author_facet | Schulz, Anna, Knebel Doeberitz, Magnus von, Kloor, Matthias |
author_role | aut, aut, aut |
author_sort | Schulz, Anna 1984- |
author_variant | a s as, d m v k dmv dmvk, m k mk |
callnumber-sort | |
collection | lfer |
container_reference | 106(2012), 6, Seite 1239-1245 |
container_title | British journal of cancer |
contents | Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials. |
ctrlnum | (DE-627)1575856409, (DE-576)505856409, (DE-599)BSZ505856409, (OCoLC)1341010401 |
doi_str_mv | 10.1038/bjc.2012.53 |
facet_avail | Online, Free |
finc_class_facet | not assigned |
footnote | Gesehen am 30.05.2018 |
format | ElectronicBookComponentPart |
format_access_txtF_mv | Article, E-Article |
format_de105 | Ebook |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_del152 | Buch |
format_detail_txtF_mv | text-online-monograph-child |
format_dezi4 | e-Book |
format_finc | Article, E-Article |
format_legacy | ElectronicBookPart |
format_strict_txtF_mv | E-Article |
geogr_code | not assigned |
geogr_code_person | Germany, Russia |
hierarchy_parent_id | 0-320420094 |
hierarchy_parent_title | British journal of cancer |
hierarchy_sequence | 106(2012), 6, Seite 1239-1245 |
hierarchy_top_id | 0-320420094 |
hierarchy_top_title | British journal of cancer |
id | 0-1575856409 |
illustrated | Not Illustrated |
imprint | 21 February 2012 |
imprint_str_mv | 21 February 2012 |
institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
is_hierarchy_id | 0-1575856409 |
is_hierarchy_title | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial |
isil_str_mv | LFER |
issn | 1532-1827 |
kxp_id_str | 1575856409 |
language | English |
last_indexed | 2023-02-16T01:35:58.075Z |
marc024a_ct_mv | 10.1038/bjc.2012.53 |
match_str | schulz2012microsatelliteinstabilityandbeta2microglobulinmutationsasprognosticmarkersincoloncancerresultsofthefogt4trial |
mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
misc_de105 | EBOOK |
multipart_link | 103746854 |
multipart_part | (103746854)106(2012), 6, Seite 1239-1245 |
names_id_str_mv | (DE-588)1057967998, (DE-627)796229406, (DE-576)413967948, (DE-588)1022165291, (DE-627)71693289X, (DE-576)364934239, (DE-588)124552803, (DE-627)363416609, (DE-576)294228616 |
oclc_num | 1341010401 |
physical | 7 |
publishDate | 21 February 2012 |
publishDateSort | 2012 |
publishPlace | |
publisher | |
record_format | marcfinc |
record_id | 505856409 |
recordtype | marcfinc |
rvk_facet | No subject assigned |
source_id | 0 |
spelling | Schulz, Anna 1984- VerfasserIn (DE-588)1057967998 (DE-627)796229406 (DE-576)413967948 aut, Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor, 21 February 2012, 7, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 30.05.2018, Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials., Knebel Doeberitz, Magnus von VerfasserIn (DE-588)1022165291 (DE-627)71693289X (DE-576)364934239 aut, Kloor, Matthias 1972- VerfasserIn (DE-588)124552803 (DE-627)363416609 (DE-576)294228616 aut, Enthalten in British journal of cancer Edinburgh : Nature Publ. Group, 1999 106(2012), 6, Seite 1239-1245 Online-Ressource (DE-627)320420094 (DE-600)2002452-6 (DE-576)103746854 1532-1827 nnns, volume:106 year:2012 number:6 pages:1239-1245 extent:7, http://dx.doi.org/10.1038/bjc.2012.53 Verlag Resolving-System kostenfrei Volltext, https://www.nature.com/articles/bjc201253 Verlag kostenfrei Volltext, https://www.nature.com/articles/bjc201253 LFER, LFER 2019-05-07T00:00:00Z |
spellingShingle | Schulz, Anna, Knebel Doeberitz, Magnus von, Kloor, Matthias, Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial, Background: High-level microsatellite instability (MSI-H) has been reported as a prognostic marker in colon cancer. We here analysed the prognostic significance of MSI and mutations of the Beta2-Microglobulin (B2M) gene, which occur in about 30% of MSI-H colon cancer, in the cohort of the prospective FOGT-4 (Forschungsruppe Onkologie Gastrointestinale Tumoren, FOGT) trial. Methods: Microsatellite instability status was determined using standard protocols (NCI/ICG-HNPCC panel and CAT25) in 223 colon cancer lesions. Beta2-Microglobulin mutation status was evaluated by exon-wise sequencing in all MSI-H lesions. Results: Patients with MSI-H (n=34) colon cancer presented with a significantly lower risk of relapse after 12 months of follow-up compared with MSS (n=189) colon cancer patients (5 year time to relapse: MSI-H 0.82 vs MSS 0.66, P=0.03). No significant difference in overall survival was detected. Beta2-Microglobulin mutations were identified in 10 (29.4%) out of 34 MSI-H colon cancers and were associated with a complete absence of disease relapse or tumour-related death events (P=0.09). Conclusion: The risk of late disease relapse was significantly lower in patients with MSI-H compared with MSS colon cancer. Moreover, B2M mutations may contribute to the favourable outcome of MSI-H colon cancer patients and should therefore be evaluated as a potential prognostic marker in future clinical trials. |
swb_id_str | 505856409 |
title | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial |
title_auth | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial |
title_full | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor |
title_fullStr | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor |
title_full_unstemmed | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer results of the FOGT-4 trial A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor |
title_in_hierarchy | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial / A. Tikidzhieva, A. Benner, S. Michel, A. Formentini, K.-H. Link, W. Dippold, M. von Knebel Doeberitz, M. Kornmann and M. Kloor, |
title_short | Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer |
title_sort | microsatellite instability and beta2 microglobulin mutations as prognostic markers in colon cancer results of the fogt 4 trial |
title_sub | results of the FOGT-4 trial |
url | http://dx.doi.org/10.1038/bjc.2012.53, https://www.nature.com/articles/bjc201253 |